89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,499,056 | -2.0% | 161,856 | +20.3% | 0.00% | 0.0% |
| Q2 2023 | $2,549,950 | -56.4% | 134,562 | -64.9% | 0.00% | -50.0% |
| Q1 2023 | $5,842,045 | -14.8% | 383,588 | -28.8% | 0.00% | -20.0% |
| Q4 2022 | $6,857,384 | +188.4% | 538,679 | +31.2% | 0.01% | +150.0% |
| Q3 2022 | $2,378,000 | +228.9% | 410,647 | +82.8% | 0.00% | +100.0% |
| Q2 2022 | $723,000 | +24000.0% | 224,627 | +25928.6% | 0.00% | – |
| Q1 2022 | $3,000 | -92.7% | 863 | -72.6% | 0.00% | – |
| Q4 2021 | $41,000 | +78.3% | 3,146 | +172.9% | 0.00% | – |
| Q3 2021 | $23,000 | +155.6% | 1,153 | +148.5% | 0.00% | – |
| Q2 2021 | $9,000 | -30.8% | 464 | -15.9% | 0.00% | – |
| Q1 2021 | $13,000 | -65.8% | 552 | -64.9% | 0.00% | – |
| Q4 2020 | $38,000 | +375.0% | 1,571 | +403.5% | 0.00% | – |
| Q3 2020 | $8,000 | 0.0% | 312 | -24.8% | 0.00% | – |
| Q2 2020 | $8,000 | -65.2% | 415 | -54.3% | 0.00% | – |
| Q1 2020 | $23,000 | +53.3% | 909 | +54.1% | 0.00% | – |
| Q4 2019 | $15,000 | – | 590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |